🔎 Trials Near Me

Beranda › Kanker Paru › Illinois › Evanston

Uji klinis Kanker Paru di Evanston, IL

19 studi untuk Kanker Paru mencari peserta di lokasi sekitar Evanston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi jauhnya
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Menerima pesertaFase 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Menerima pesertaFase 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Menerima pesertaFase 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Illinois Cancer Specialists, Niles · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Menerima pesertaFase 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06758401

A Registry for People With Lung Cancer

Menerima pesertaStudi observasional
  • Endeavor Health, Evanston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06424327

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Menerima pesertaFase 3
  • Illinois Cancer Specialists, Niles · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Menerima pesertaFase 2
  • Advocate Aurora Health, Park Ridge · 8 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
18 Minutes · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Menerima pesertaSukarelawan sehat diterima
  • Northwestern University, Evanston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT06196008

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Menerima pesertaStudi observasional
  • Northshore University Health System, Evanston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05974150

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Menerima pesertaStudi observasional
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT06073431

Uji klinis Kanker Paru di kota lain

Studi lain di Evanston

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.